课题基金 / 基金详情

A Role of HMGIC in Squamous Carcinoma Cells of The Oral Cavity

A Role of HMGIC in Squamous Carcinoma Cells of The Oral Cavity
HMGIC 在口腔鳞状细胞癌中的作用
批准号:
16591898
负责人:
IMAI Kazushi
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

IMAI Kazushi的其他基金

相似基金

相关文献

中文摘要
翻译
在先前的研究中,我们发现转录因子高迁移率族蛋白(HMGIC/HMGA2)在口腔癌中的表达频繁,并与患者的5年生存率有关。了解HMGIC表达的作用应该扩大对癌症进展的分子机制(S)的知识。为此,我们开发了一种新的高通量分析方法,称为SChIP,用于揭示HMGA2靶基因。我们确定了大约。100个基因,集中在5个不同的基因上,这些基因有望参与口腔癌的进展。RT-PCR结果显示,这5个基因在分化的HaCaT角质形成细胞中几乎不表达,而在未分化的HaCaT细胞中表达上调。此外,未表达HMGIC基因的口腔癌细胞(KOSC3、Ho1u1)不表达这5个基因,而表达HMGIC基因的口腔癌细胞(HOC313、TSU)则不表达这5个基因。为了了解HMGIC的转录活性,我们目前正在通过荧光素酶系统的报告分析来研究它。HMGIC靶基因在从缺氢小鼠分离的角质形成细胞中的表达也在调查中。我们将建立通过RNAi特异性击倒HMGA2基因的癌细胞株,并分析HMGIC和靶基因对肿瘤的致瘤性、侵袭性、转移潜能和表型变化的直接作用。
英文摘要
In a previous study, we showed that expression of a transcription factor-high mobility group protein (HMGIC/HMGA2), which plays a critical role in differentiation and growth of un-differentiated mesenchymal cells during development, is frequently observed in oral carcinomas and associates with 5-year survival rate of patients suffered from the disease. Understanding a role of HMGIC expression should expand knowledge of a molecular mechanism(s) of cancer progression. In this end, we developed a novel high-throughput analysis, named sChIP, to unveil HMGA2 target genes. We identified approx. 100 genes, and focused on 5 different genes, which are expected to be involved in the progression of oral carcinomas. RT-PCR showed that expression of these 5 genes were negligible in differentiated HaCaT keratinocytes but upregulated in undifferentiated HaCaT cells. In addition, oral carcinoma cells without HMGIC expression (KOSC3, Ho1u1) did not express these 5 genes in contrast to the expression in carcinoma cells expressing HMGIC gene (HOC313, TSU). To understand the transcriptional activity of HMGIC, we are currently investigating it by a reporter assay using luciferase system. Expression of HMGIC target genes in keratinocytes isolated from Hmgic-null mice is also under investigation. We will develop carcinoma cell lines which are specifically knock-downed HMGA2 gene by RNAi, and analyze a direct role of HMGIC and the target genes on tumorgenisity, and invasiveness, metastatic potential and phenotypic alterations of carcinoma cells.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3892/ijo.27.6.1535
发表时间: 2005-12
期刊: International journal of oncology
影响因子: 5.2
作者: [G. Maeda;T. Chiba;M. Okazaki;T. Satoh;Y. Taya;T. Aoba;K. Kato;S. Kawashiri;K. Imai]
通讯作者: G. Maeda;T. Chiba;M. Okazaki;T. Satoh;Y. Taya;T. Aoba;K. Kato;S. Kawashiri;K. Imai
Ectopic activation of mesenchyme-specific genes induce the epithelial mesenchymal transition in oral cancer.
间充质特异性基因的异位激活诱导口腔癌的上皮间质转化。
DOI: --
发表时间: 2005
期刊: Res.Adv.in Cancer 5
影响因子: --
作者: [M.Nasu, F.Mitsuhashi, T.Yosue et al., Kazushi Imai]
通讯作者: Kazushi Imai
Ectopic activation of mesenchyme-specific genes induce the epithelial-mesenchymal transition in oral cancer, in "Research Advances in Cancer"
间充质特异性基因的异位激活诱导口腔癌的上皮间充质转化,在“癌症研究进展”中
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [Aida Y, Maeno M, Suzuki N, Shiratsuchi H, Motohashi M, Matsumura H., Kazushi Imai]
通讯作者: Kazushi Imai
転写因子の標的遺伝子検出方法
一种转录因子靶基因的检测方法
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: []
通讯作者:
共 7 条
    Inhibition of NFκB activity by MALT1 and its involvement in phenotypic alterations of oral carcinoma cells
    • 批准号:
      22592103
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2010
    • 负责人:
      IMAI Kazushi
    • 依托单位:
    Astudy on the mechanism of oral carcinoma progression upon the suppression of NF kB transcriptional activity by the nucleus-localization MALT1.
    • 批准号:
      18592073
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      2006
    • 负责人:
      IMAI Kazushi
    • 依托单位:
    国内基金
    海外基金
    CircSKA3通过抑制HMGA2泛素化降解调控巨噬细胞M2型分化促进卵巢癌转移的机制研究
    • 批准号:
      QN25H160107
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      邓静雯
    • 依托单位:
    Fra-1通过转录激活胃癌细胞HMGA2表达调控巨噬细胞极化的机制研究
    • 批准号:
      2025JJ80863
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      许娟
    • 依托单位:
    HMGA2介导TMAO抑制结直肠癌细胞铁死亡的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      蒋海忠
    • 依托单位:
    XPA结合蛋白2通过HMGA2可变剪接影响卵巢癌铂耐药的机制研究
    • 批准号:
      2025JJ70423
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      田焱
    • 依托单位: